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EVIDENCE BASED NEURO-ONCOLOGY
Cerebellar Mutism Syndrome after surgical resection of posterior fossa
neoplastic lesions.
Saqib Kamran Bakhshi, Rida Mitha, Naureen Mushtaq, Muhammad Shahzad Shamim.

Abstract
Cerebellar Mutism Syndrome (CMS) is a well-described
clinical entity that complicates surgeries for posterior fossa
tumours; more so in children than adults. This review
focuses on the current understanding of CMS, its incidence
and risk factors. Incidence showed a variable range in
retrospective studies due to variety of deﬁnitions. Risk
factors can be classiﬁed as either modiﬁable including
surgical technique, or non-modiﬁable which include
tumour related factors. A positive correlation has been
associated between tumour pathology, brain stem invasion
and size of tumour at time of presentation with
development of CMS.
Keywords: Pediatric brain tumors, cerebellar mutism
syndrome, posterior fossa syndrome

Introduction

Figure 1A: Pre-operative T1 post-contrast sagittal section of MRI brain of a 3 years
old boy showing a homogenously contrast enhancing lesion in the posterior
fossa, causing hydrocephalus and significant mass effect on brainstem.

Cerebellar mutism syndrome (CMS), often used
interchangeably with posterior fossa syndrome (PFS), is not
an uncommon complication, following surgical resection
of tumours located in the cerebellum or fourth ventricle.1
Cerebellar mutism was initially described as ‘akinetic
mutism’ by Daly and Love in 1958 after the removal of a
cerebellar tumour in a child. Historically, it comprised of
complete loss of speech that was not associated with
cranial nerve palsies, long tract signs or alteration of
consciousness; and typically occurred within few hours to
several days after posterior fossa tumour surgery.2
However, CMS is now used to describe a broader clinical
condition which comprises of transient speech impairment,
decreased muscle tone, irritability, ataxia and psychosis
mostly in children and young adults, usually following
surgery for posterior fossa tumours.3
The incidence of CMS has been reported in 8% to 32%
children, however, there is signiﬁcant discrepancy in this
number because of high variability of deﬁnitions of CMS
used by diﬀerent authors.4 Patients show inconsistent
recovery in a variable amount of time, with some regaining
the lost function completely, but most having some
residual dysarthria, ataxia or intellectual disability. CMS is
commonly believed to be caused by destruction of the
reciprocal cerebello-cerebral pathway and bilateral dentate
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Figure 1B: PPost-operative T1 post-contrast sagittal section of MRI brain of the same
patient showing resection cavity filled with fluid, and interval reduction in
mass effect on brainstem and cerebellum as well as hydrocephalus.

nuclei. This disrupts dentate-thalamo-cerebral tract, which
impairs corresponding areas of the cerebral cortex.4 Risk
factors are mostly non-modiﬁable and include larger
tumours (>5cm in diameter) located in the midline,
brainstem invasion and pre-operative language deﬁcits.4 It
is commonly associated with medulloblastoma (40%),
ependymomas (20%) and astrocytomas (15%).4
Owing to advancement in surgical techniques, and early
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diagnosis of posterior fossa tumours due to wider
availability of magnetic resonance imaging (MRI), there has
been an increase in posterior fossa surgeries and attempts
for gross total resection, as one of the most important
prognostic indicators in patients with posterior fossa
tumours is extent of surgical resection. This theoretically
increases the risk of developing CMS. Herein, we have
reviewed the existing English language literature on CMS
after surgical resection of posterior fossa brain tumours.

Review of Evidence
We searched ‘cerebellar mutism syndrome’, akinetic mutism’
and ‘posterior fossa syndrome’ on PubMed and Google
scholar database. Despite a high reported incidence, the
condition has not been very commonly studied. Robertson
et al., published a large prospective multicenter study
between 1994 and 2000, and studied 450 patients who had
undergone craniotomy and resection of posterior fossa
medulloblastoma.5 They reported incidence of CMS in 107
patients (24%) within two months from surgery, and
classiﬁed it into severe (43%), moderate (49%) and mild
(8%) using a CMS survey that they had speciﬁcally designed
for this study. The only signiﬁcant risk factor with a positive
correlation with CMS was brainstem invasion, whereas
radical surgical resection was not a signiﬁcant risk factor.
They also found variable extent of recovery in most
patients, but fewer patients attained complete recovery up
to 1 year after surgery. Korah et al., in their retrospective
series reviewed 63 children who had undergone surgical
resection of medulloblastoma.6 Their median follow-up
time was 7 years, and incidence of CMS was 29% (18
patients). This study reported younger age, gross total
resection, midline location of tumour and brainstem
invasion to be statistically signiﬁcant predictors of CMS.
Another case series of 32 children who underwent
resection of cerebellar tumours was published by Kotil et
al., who reported the occurrence of CMS in 10 children
(32%).7 They found larger tumour size and midline location
to be signiﬁcant risk factors for developing CMS. Although
CMS or PFS have been predominantly described to occur
in children, some cases in adults have also been reported.
In 2019, Shamov et al., reported post-operative CMS in a 25
years old female patient after resection of 4th ventricular
medulloblastoma, which was the eighth such case in
literature.8 They attributed excessive use of bipolar cautery
and ultrasonic aspirator in close proximity to the
cerebellum to be possible causes.
Cobourn et al., had performed a retrospective review of 65
patients who had undergone surgical resection of posterior
fossa tumours at their center, and studied relation between
important surgical steps and CMS.9 They reported
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incidence of CMS in 7 of their patients (10.8%) and found
degree of cerebellar retraction and incision of vermis to be
signiﬁcant risk factors for CMS. In the light of their results,
they recommended preference of telo-velar approach over
trans-vermian approach for posterior fossa tumour
resection. In another recent study, Dhaenens et al., had
retrospectively reviewed MRI scans of 121 children with
posterior fossa tumour who underwent surgery, and
attempted to design and validate a preoperative risk
prediction model for post-operative CMS.10 Twenty six
percent of their patients had developed CMS. In their
radiological risk prediction model they included Evan’s
ratio, distance and angle between basilar artery and
tumour and depth of invasion/compression and area of
contact between brainstem and the tumour. Their
proposed model had a sensitivity of 97% and speciﬁcity of
84% in pre-operative prediction of CMS.10

Conclusion
The review of available literature shows CMS/PFS to be an
important complication following posterior fossa tumour
resection. Important modiﬁable risk factor may include
surgical technique that avoids manipulation of vermis.
However, more common factors responsible for this
condition include tumour location, pathology and size.
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